Highlights Newsletter 3
This newsletter presents you the following best read key sessions:
1. Podcast with dr. Manish R. Patel about the efficacy and safety of entrectinib in NTRK fusion-positive
gastrointestinal cancers
2. Also older patients with previously untreated unresectable hepatocellular carcinoma derive more clinical
benefit from atezolizumab-bevacizumab compared to sorafenib
5. Perioperative systemic therapy: feasible, safe and tolerable in patients with isolated colorectal peritoneal
metastases